PIK3C2B
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta
Also known as: C2-PI3K, P3C2B_HUMAN, PI3K-C2beta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00750
- Gene
- PIK3C2B
- Ensembl
- ENSG00000133056
- Chromosome
- 1
- Canonical length
- 1634 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the phosphoinositide 3-kinase (PI3K) family. PI3-kinases play roles in signaling pathways involved in cell proliferation, oncogenic transformation, cell survival, cell migration, and intracellular protein trafficking. This protein contains a lipid kinase catalytic domain as well as a C-terminal C2 domain, a characteristic of class II PI3-kinases. C2 domains act as calcium-dependent phospholipid binding motifs that mediate translocation of proteins to membranes, and may also mediate protein-protein interactions. The PI3-kinase activity of this protein is sensitive to low nanomolar levels of the inhibitor wortmanin. The C2 domain of this protein was shown to bind phospholipids but not Ca2+, which suggests that this enzyme may function in a calcium-independent manner. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1634 residues, UniProt reviewed canonical sequence.
>O00750|PIK3C2B
1 MSSTQGNGEH WKSLESVGIS RKELAMAEAL QMEYDALSRL RHDKEENRAK QNADPSLISW
61 DEPGVDFYSK PAGRRTDLKL LRGLSGSDPT LNYNSLSPQE GPPNHSTSQG PQPGSDPWPK
121 GSLSGDYLYI FDGSDGGVSS SPGPGDIEGS CKKLSPPPLP PRASIWDTPP LPPRKGSPSS
181 SKISQPSDIN TFSLVEQLPG KLLEHRILEE EEVLGGGGQG RLLGSVDYDG INDAITRLNL
241 KSTYDAEMLR DATRGWKEGR GPLDFSKDTS GKPVARSKTM PPQVPPRTYA SRYGNRKNAT
301 PGKNRRISAA PVGSRPHTVA NGHELFEVSE ERDEEVAAFC HMLDILRSGS DIQDYFLTGY
361 VWSAVTPSPE HLGDEVNLKV TVLCDRLQEA LTFTCNCSST VDLLIYQTLC YTHDDLRNVD
421 VGDFVLKPCG LEEFLQNKHA LGSHEYIQYC RKFDIDIRLQ LMEQKVVRSD LARTVNDDQS
481 PSTLNYLVHL QERPVKQTIS RQALSLLFDT YHNEVDAFLL ADGDFPLKAD RVVQSVKAIC
541 NALAAVETPE ITSALNQLPP CPSRMQPKIQ KDPSVLAVRE NREKVVEALT AAILDLVELY
601 CNTFNADFQT AVPGSRKHDL VQEACHFARS LAFTVYATHR IPIIWATSYE DFYLSCSLSH
661 GGKELCSPLQ TRRAHFSKYL FHLIVWDQQI CFPVQVNRLP RETLLCATLY ALPIPPPGSS
721 SEANKQRRVP EALGWVTTPL FNFRQVLTCG RKLLGLWPAT QENPSARWSA PNFHQPDSVI
781 LQIDFPTSAF DIKFTSPPGD KFSPRYEFGS LREEDQRKLK DIMQKESLYW LTDADKKRLW
841 EKRYYCHSEV SSLPLVLASA PSWEWACLPD IYVLLKQWTH MNHQDALGLL HATFPDQEVR
901 RMAVQWIGSL SDAELLDYLP QLVQALKYEC YLDSPLVRFL LKRAVSDLRV THYFFWLLKD
961 GLKDSQFSIR YQYLLAALLC CCGKGLREEF NRQCWLVNAL AKLAQQVREA APSARQGILR
1021 TGLEEVKQFF ALNGSCRLPL SPSLLVKGIV PRDCSYFNSN AVPLKLSFQN VDPLGENIRV
1081 IFKCGDDLRQ DMLTLQMIRI MSKIWVQEGL DMRMVIFRCF STGRGRGMVE MIPNAETLRK
1141 IQVEHGVTGS FKDRPLADWL QKHNPGEDEY EKAVENFIYS CAGCCVATYV LGICDRHNDN
1201 IMLKTTGHMF HIDFGRFLGH AQMFGNIKRD RAPFVFTSDM AYVINGGDKP SSRFHDFVDL
1261 CCQAYNLIRK HTHLFLNLLG LMLSCGIPEL SDLEDLKYVY DALRPQDTEA NATTYFTRLI
1321 ESSLGSVATK LNFFIHNLAQ MKFTGSDDRL TLSFASRTHT LKSSGRISDV FLCRHEKIFH
1381 PNKGYIYVVK VMRENTHEAT YIQRTFEEFQ ELHNKLRLLF PSSHLPSFPS RFVIGRSRGE
1441 AVAERRREEL NGYIWHLIHA PPEVAECDLV YTFFHPLPRD EKAMGTSPAP KSSDGTWARP
1501 VGKVGGEVKL SISYKNNKLF IMVMHIRGLQ LLQDGNDPDP YVKIYLLPDP QKTTKRKTKV
1561 ARKTCNPTYN EMLVYDGIPK GDLQQRELQL SVLSEQGFWE NVLLGEVNIR LRELDLAQEK
1621 TGWFALGSRS HGTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIK3C2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 19 nTPM
- lymph node: 18 nTPM
- tonsil: 18 nTPM
- skin: 18 nTPM
- thymus: 18 nTPM
- stomach: 13 nTPM
Single-cell type
- oligodendrocytes: 175 nCPM
- vascular endothelial cells: 114 nCPM
- bergmann glia: 108 nCPM
- foveolar cells: 98 nCPM
- urothelial cells: 87 nCPM
- prostatic hillock cells: 81 nCPM
Immune cell
- naive B-cell: 1.7 nTPM
- memory B-cell: 0.7 nTPM
- T-reg: 0.7 nTPM
- NK-cell: 0.5 nTPM
- MAIT T-cell: 0.3 nTPM
- memory CD4 T-cell: 0.3 nTPM
Brain region
- white matter: 66 nTPM
- cerebral cortex: 52 nTPM
- thalamus: 48 nTPM
- basal ganglia: 46 nTPM
- midbrain: 43 nTPM
- medulla oblongata: 41 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.55
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome organization
- cell migration
- cellular response to starvation
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- phosphatidylinositol-3-phosphate biosynthetic process
- phosphatidylinositol-mediated signaling
Molecular functions
- 1-phosphatidylinositol-3-kinase activity
- 1-phosphatidylinositol-4-phosphate 3-kinase activity
- ATP binding
- phosphatidylinositol binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain
- Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain
- Phosphatidylinositol 3-/4-kinase, catalytic domain
- Phosphoinositide 3-kinase, accessory (PIK) domain
- Phox homology
- C2 phosphatidylinositol 3-kinase-type domain
- Protein kinase-like domain superfamily
- Phosphatidylinositol 3-/4-kinase
- Armadillo-type fold
- Phosphatidylinositol 3-/4-kinase, conserved site
- Ubiquitin-like domain superfamily
- C2 domain superfamily
- PX domain superfamily
- Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily
- Phosphoinositide 3-kinase, accessory (PIK) domain superfamily
- C2 domain
- Phosphatidylinositol 3- and 4-kinase
- Phosphoinositide 3-kinase family, accessory domain (PIK domain)
- PX domain
- Phosphoinositide 3-kinase C2
- PI3-kinase family, ras-binding domain
- Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta, PX domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIK3C2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIK3C2B as an antibody target. Whether an autoantibody or antibody against PIK3C2B could matter depends on whether native PIK3C2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIK3C2B is annotated at the cell surface, where native PIK3C2B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PIK3C2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...